The fenofibrate micronized powders were prepared using lactose and MCC as the main expicients for preparation of fenofibrate tablets.
乳糖和微晶纤维素作为主要辅料制备
特的微粉化物,并
此制备片剂,辅
预胶化淀粉调节片剂的溶出度。
The fenofibrate micronized powders were prepared using lactose and MCC as the main expicients for preparation of fenofibrate tablets.
乳糖和微晶纤维素作为主要辅料制备
特的微粉化物,并
此制备片剂,辅
预胶化淀粉调节片剂的溶出度。
Similarly, fenofibrate and the combination (but not simvastatin) significantly increased the percentage of buoyant LDL cholesterol constituting total LDL cholesterol.
类似的,特和联合治疗显著升高有浮力的LDL在总LDL中的比例。
Objective To investigate the effects of micronized fenofibrate on low density lipoprotein (LDL) subfraction profiles in type IV hyperlipidemic subjects.
目的观察微粒化特对IV型高脂血症患者血清低密度脂蛋白(LDL)亚组份再分布的作用。
声:
例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
The fenofibrate micronized powders were prepared using lactose and MCC as the main expicients for preparation of fenofibrate tablets.
以乳糖和微晶纤维素作为主要辅料非
贝特
微粉化物,并以
片剂,辅以预胶化淀粉调节片剂
溶出度。
Similarly, fenofibrate and the combination (but not simvastatin) significantly increased the percentage of buoyant LDL cholesterol constituting total LDL cholesterol.
类似,非
贝特和联合治疗显著升高有浮力
LDL在总LDL中
比例。
Objective To investigate the effects of micronized fenofibrate on low density lipoprotein (LDL) subfraction profiles in type IV hyperlipidemic subjects.
察微粒化非
贝特对IV型高脂血症患者血清低密度脂蛋白(LDL)亚组份再分布
作用。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件点;若发现问题,欢迎向我们指正。
The fenofibrate micronized powders were prepared using lactose and MCC as the main expicients for preparation of fenofibrate tablets.
以乳糖和微晶纤维素作为主要辅料制备非贝特
微粉化物,并以此制备
,辅以预胶化淀粉调节
溶出度。
Similarly, fenofibrate and the combination (but not simvastatin) significantly increased the percentage of buoyant LDL cholesterol constituting total LDL cholesterol.
类似,非
贝特和联合治疗
高有浮力
LDL在总LDL中
比例。
Objective To investigate the effects of micronized fenofibrate on low density lipoprotein (LDL) subfraction profiles in type IV hyperlipidemic subjects.
目观察微粒化非
贝特对IV型高脂血症患者血清低密度脂蛋白(LDL)亚组份再分布
作用。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件观点;若发现问题,欢迎向我们指正。
The fenofibrate micronized powders were prepared using lactose and MCC as the main expicients for preparation of fenofibrate tablets.
以乳糖和晶纤维素作为主要辅料制备非
粉化物,并以此制备片剂,辅以预胶化淀粉调节片剂
溶出度。
Similarly, fenofibrate and the combination (but not simvastatin) significantly increased the percentage of buoyant LDL cholesterol constituting total LDL cholesterol.
类似,非
和联合治疗显著升高有浮力
LDL在总LDL中
比例。
Objective To investigate the effects of micronized fenofibrate on low density lipoprotein (LDL) subfraction profiles in type IV hyperlipidemic subjects.
目观察
粒化非
对IV型高脂血症患者血清低密度脂蛋白(LDL)亚组份再分布
作用。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件观点;若发现问题,欢迎向我们指正。
The fenofibrate micronized powders were prepared using lactose and MCC as the main expicients for preparation of fenofibrate tablets.
以乳糖和微晶纤维素作为主要辅料制备非贝特的微粉化物,并以此制备片剂,辅以预胶化淀粉调节片剂的溶
。
Similarly, fenofibrate and the combination (but not simvastatin) significantly increased the percentage of buoyant LDL cholesterol constituting total LDL cholesterol.
似的,非
贝特和
疗显著升高有浮力的LDL在总LDL中的比例。
Objective To investigate the effects of micronized fenofibrate on low density lipoprotein (LDL) subfraction profiles in type IV hyperlipidemic subjects.
目的观察微粒化非贝特对IV型高脂血症患者血清低密
脂蛋白(LDL)亚组份再分布的作用。
声明:以上例句、词性分均由互
网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
The fenofibrate micronized powders were prepared using lactose and MCC as the main expicients for preparation of fenofibrate tablets.
乳糖和微晶纤维素作为主要辅料制备
贝特的微粉化物,并
此制备片剂,辅
预胶化淀粉调节片剂的溶出度。
Similarly, fenofibrate and the combination (but not simvastatin) significantly increased the percentage of buoyant LDL cholesterol constituting total LDL cholesterol.
类似的,贝特和联合治疗显著升高有浮力的LDL在总LDL中的比
。
Objective To investigate the effects of micronized fenofibrate on low density lipoprotein (LDL) subfraction profiles in type IV hyperlipidemic subjects.
目的观察微粒化贝特对IV型高脂血症患者血清低密度脂蛋白(LDL)亚组份再分布的作用。
声明:句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
The fenofibrate micronized powders were prepared using lactose and MCC as the main expicients for preparation of fenofibrate tablets.
以乳糖和微晶纤维素作为主要辅料非
贝特
微粉化物,并以此
剂,辅以预胶化淀粉调节
剂
溶出度。
Similarly, fenofibrate and the combination (but not simvastatin) significantly increased the percentage of buoyant LDL cholesterol constituting total LDL cholesterol.
类似,非
贝特和联合治疗显著升高有浮力
LDL在总LDL中
比
。
Objective To investigate the effects of micronized fenofibrate on low density lipoprotein (LDL) subfraction profiles in type IV hyperlipidemic subjects.
观察微粒化非
贝特对IV型高脂血症患者血清低密度脂蛋白(LDL)亚组份再分布
作用。
声明:以上句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件
观点;若发现问题,欢迎向我们指正。
The fenofibrate micronized powders were prepared using lactose and MCC as the main expicients for preparation of fenofibrate tablets.
糖和微晶纤维素作为主要辅料制备非
贝特的微粉化物,并
此制备片剂,辅
预胶化淀粉调节片剂的溶出度。
Similarly, fenofibrate and the combination (but not simvastatin) significantly increased the percentage of buoyant LDL cholesterol constituting total LDL cholesterol.
类似的,非贝特和联合治疗显著升高有浮力的LDL在总LDL中的比例。
Objective To investigate the effects of micronized fenofibrate on low density lipoprotein (LDL) subfraction profiles in type IV hyperlipidemic subjects.
目的观察微粒化非贝特对IV型高脂血症患者血清低密度脂蛋白(LDL)亚组
布的作用。
声明:上例句、词性
类均由互联网资源自动生成,部
未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
The fenofibrate micronized powders were prepared using lactose and MCC as the main expicients for preparation of fenofibrate tablets.
以乳糖和微晶纤维素作为主要辅料制备非贝特
微粉化物,并以此制备片剂,辅以预胶化淀粉调节片剂
度。
Similarly, fenofibrate and the combination (but not simvastatin) significantly increased the percentage of buoyant LDL cholesterol constituting total LDL cholesterol.
类似,非
贝特和联合
著升高有浮力
LDL在总LDL中
比例。
Objective To investigate the effects of micronized fenofibrate on low density lipoprotein (LDL) subfraction profiles in type IV hyperlipidemic subjects.
目观察微粒化非
贝特对IV型高脂血症患者血清低密度脂蛋白(LDL)亚组份再分布
作用。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件观点;若发现问题,欢迎向我们指正。